Charles River Laboratories snaps up Cognate for a cool $875M, looks to expand cell and gene therapy CDMO foothold
With the cell and gene therapy space as hot as ever, big-name CDMO Charles River Laboratories is looking to carve out a big piece of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
